BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 23906320)

  • 1. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
    Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
    Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass reactivity to Trypanosoma cruzi in chronic chagasic patients.
    Hernández-Becerril N; Nava A; Reyes PA; Monteón VM
    Arch Cardiol Mex; 2001; 71(3):199-205. PubMed ID: 11665655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy to assess the overall cytokine profile of circulating leukocytes and its association with distinct clinical forms of human Chagas disease.
    Vitelli-Avelar DM; Sathler-Avelar R; Teixeira-Carvalho A; Pinto Dias JC; Gontijo ED; Faria AM; Elói-Santos SM; Martins-Filho OA
    Scand J Immunol; 2008 Nov; 68(5):516-25. PubMed ID: 18803607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological imbalance between IFN-gamma and IL-10 levels in the sera of patients with the cardiac form of Chagas disease.
    D'Avila DA; Guedes PM; Castro AM; Gontijo ED; Chiari E; Galvão LM
    Mem Inst Oswaldo Cruz; 2009 Feb; 104(1):100-5. PubMed ID: 19274383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.
    Vitelli-Avelar DM; Sathler-Avelar R; Wendling AP; Rocha RD; Teixeira-Carvalho A; Martins NE; Dias JC; Rassi A; Luquetti AO; Elói-Santos SM; Martins-Filho OA
    J Immunol Methods; 2007 Jan; 318(1-2):102-12. PubMed ID: 17161421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine levels in serious cardiopathy of Chagas disease after in vitro stimulation with recombinant antigens from Trypanosoma cruzi.
    Lorena VM; Lorena IM; Braz SC; Melo AS; Melo MF; Melo MG; Silva ED; Ferreira AG; Morais CN; Costa VM; Correa-Oliveira R; Gomes YM
    Scand J Immunol; 2010 Dec; 72(6):529-39. PubMed ID: 21044127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Trypanosoma cruzi antibody isotype profiles in patients with different clinical manifestations of Chagas' disease.
    Morgan J; Dias JC; Gontijo ED; Bahia-Oliveira L; Correa-Oliveira R; Colley DG; Powell MR
    Am J Trop Med Hyg; 1996 Oct; 55(4):355-9. PubMed ID: 8916788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-house ELISA method to analyze anti-Trypanosoma cruzi IgG reactivity for differential diagnosis and evaluation of Chagas disease morbidity.
    Santos Lda S; Torres RM; Machado-de-Assis GF; Bahia MT; Martins HR; Teixeira-Carvalho A; Coelho-Dos-Reis JG; Albajar-Viñas P; Martins-Filho OA; Lana Md
    Rev Soc Bras Med Trop; 2012 Feb; 45(1):35-44. PubMed ID: 22370826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity.
    Georg I; Hasslocher-Moreno AM; Xavier SS; Holanda MT; Roma EH; Bonecini-Almeida MDG
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005796. PubMed ID: 28723905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease.
    Reis DD; Gazzinelli RT; Gazzinelli G; Colley DG
    J Immunol; 1993 Feb; 150(4):1611-8. PubMed ID: 8432996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and laboratory status of patients with chronic Chagas disease living in a vector-controlled area in Minas Gerais, Brazil, before and nine years after aetiological treatment.
    Lana Md; Lopes LA; Martins HR; Bahia MT; Machado-de-Assis GF; Wendling AP; Martins-Filho OA; Montoya RA; Dias JC; Albajar-Viñas P; Coura JR
    Mem Inst Oswaldo Cruz; 2009 Dec; 104(8):1139-47. PubMed ID: 20140375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in isotype composition and antigen recognition of anti-Trypanosoma cruzi antibodies from acute to chronic Chagas disease.
    Umezawa ES; Shikanai-Yasuda MA; Stolf AM
    J Clin Lab Anal; 1996; 10(6):407-13. PubMed ID: 8951611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients.
    Verçosa AF; Lorena VM; Carvalho CL; Melo MF; Cavalcanti MG; Silva ED; Ferreira AG; Pereira VR; Souza WV; Gomes YM
    J Clin Lab Anal; 2007; 21(5):271-6. PubMed ID: 17847109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chagas' disease: polyspecificity of antibodies against Trypanosoma cruzi acidic antigens.
    Ordoñez P; Gea S; Iosa D; Vottero-Cima E
    Acta Trop; 1995 May; 59(2):93-103. PubMed ID: 7676911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
    Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
    J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cross-reactive host-pathogen antibodies in patients with different stages of chronic Chagas disease.
    Vicco MH; Ferini F; Rodeles L; Cardona P; Bontempi I; Lioi S; Beloscar J; Nara T; Marcipar I; Bottasso OA
    Rev Esp Cardiol (Engl Ed); 2013 Oct; 66(10):791-6. PubMed ID: 24773859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to human heart conduction system in Chagas' disease.
    Arce-Fonseca M; Ballinas-Verdugo MA; Reyes PA; Aranda-Fraustro A; Monteón VM
    Vector Borne Zoonotic Dis; 2005; 5(3):233-6. PubMed ID: 16187891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre- and post-transplant anti-myosin and anti-heat shock protein antibodies and cardiac transplant outcome.
    Morgun A; Shulzhenko N; Unterkircher CS; Diniz RV; Pereira AB; Silva MS; Nishida SK; Almeida DR; Carvalho AC; Franco M; Souza MM; Gerbase-DeLima M
    J Heart Lung Transplant; 2004 Feb; 23(2):204-9. PubMed ID: 14761768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen.
    Cunha-Neto E; Duranti M; Gruber A; Zingales B; De Messias I; Stolf N; Bellotti G; Patarroyo ME; Pilleggi F; Kalil J
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3541-5. PubMed ID: 7536937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.